These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 11583628)
1. The TGF beta receptor activation process: an inhibitor- to substrate-binding switch. Huse M; Muir TW; Xu L; Chen YG; Kuriyan J; Massagué J Mol Cell; 2001 Sep; 8(3):671-82. PubMed ID: 11583628 [TBL] [Abstract][Full Text] [Related]
2. Structural basis of Smad2 recognition by the Smad anchor for receptor activation. Wu G; Chen YG; Ozdamar B; Gyuricza CA; Chong PA; Wrana JL; Massagué J; Shi Y Science; 2000 Jan; 287(5450):92-7. PubMed ID: 10615055 [TBL] [Abstract][Full Text] [Related]
3. The transcriptional co-activator P/CAF potentiates TGF-beta/Smad signaling. Itoh S; Ericsson J; Nishikawa J; Heldin CH; ten Dijke P Nucleic Acids Res; 2000 Nov; 28(21):4291-8. PubMed ID: 11058129 [TBL] [Abstract][Full Text] [Related]
4. Functional conservation of Schistosoma mansoni Smads in TGF-beta signaling. Beall MJ; McGonigle S; Pearce EJ Mol Biochem Parasitol; 2000 Nov; 111(1):131-42. PubMed ID: 11087923 [TBL] [Abstract][Full Text] [Related]
5. Crystal structure of a phosphorylated Smad2. Recognition of phosphoserine by the MH2 domain and insights on Smad function in TGF-beta signaling. Wu JW; Hu M; Chai J; Seoane J; Huse M; Li C; Rigotti DJ; Kyin S; Muir TW; Fairman R; Massagué J; Shi Y Mol Cell; 2001 Dec; 8(6):1277-89. PubMed ID: 11779503 [TBL] [Abstract][Full Text] [Related]
6. Two short segments of Smad3 are important for specific interaction of Smad3 with c-Ski and SnoN. Mizuide M; Hara T; Furuya T; Takeda M; Kusanagi K; Inada Y; Mori M; Imamura T; Miyazawa K; Miyazono K J Biol Chem; 2003 Jan; 278(1):531-6. PubMed ID: 12426322 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of transforming growth factor-beta signaling by low molecular weight compounds interfering with ATP- or substrate-binding sites of the TGF beta type I receptor kinase. Yakymovych I; Engström U; Grimsby S; Heldin CH; Souchelnytskyi S Biochemistry; 2002 Sep; 41(36):11000-7. PubMed ID: 12206672 [TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta- and Activin-Smad signaling pathways are activated at distinct maturation stages of the thymopoeisis. Rosendahl A; Speletas M; Leandersson K; Ivars F; Sideras P Int Immunol; 2003 Dec; 15(12):1401-14. PubMed ID: 14645149 [TBL] [Abstract][Full Text] [Related]
9. The N domain of Smad7 is essential for specific inhibition of transforming growth factor-beta signaling. Hanyu A; Ishidou Y; Ebisawa T; Shimanuki T; Imamura T; Miyazono K J Cell Biol; 2001 Dec; 155(6):1017-27. PubMed ID: 11739411 [TBL] [Abstract][Full Text] [Related]
10. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor. Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141 [TBL] [Abstract][Full Text] [Related]
11. TbetaRI phosphorylation of Smad2 on Ser465 and Ser467 is required for Smad2-Smad4 complex formation and signaling. Abdollah S; Macías-Silva M; Tsukazaki T; Hayashi H; Attisano L; Wrana JL J Biol Chem; 1997 Oct; 272(44):27678-85. PubMed ID: 9346908 [TBL] [Abstract][Full Text] [Related]
12. TGF-beta-signaling with small molecule FKBP12 antagonists that bind myristoylated FKBP12-TGF-beta type I receptor fusion proteins. Stockwell BR; Schreiber SL Chem Biol; 1998 Jul; 5(7):385-95. PubMed ID: 9662508 [TBL] [Abstract][Full Text] [Related]
13. Phosphorylation regulation of the interaction between Smad7 and activin type I receptor. Liu X; Nagarajan RP; Vale W; Chen Y FEBS Lett; 2002 May; 519(1-3):93-8. PubMed ID: 12023024 [TBL] [Abstract][Full Text] [Related]
14. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4. Nakao A; Imamura T; Souchelnytskyi S; Kawabata M; Ishisaki A; Oeda E; Tamaki K; Hanai J; Heldin CH; Miyazono K; ten Dijke P EMBO J; 1997 Sep; 16(17):5353-62. PubMed ID: 9311995 [TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of a Smad2 homologue from Schistosoma mansoni, a transforming growth factor-beta signal transducer. Osman A; Niles EG; LoVerde PT J Biol Chem; 2001 Mar; 276(13):10072-82. PubMed ID: 11152451 [TBL] [Abstract][Full Text] [Related]
16. Probing the role of homomeric and heteromeric receptor interactions in TGF-beta signaling using small molecule dimerizers. Stockwell BR; Schreiber SL Curr Biol; 1998 Jun; 8(13):761-70. PubMed ID: 9651680 [TBL] [Abstract][Full Text] [Related]
17. TGF-beta inhibits p70 S6 kinase via protein phosphatase 2A to induce G(1) arrest. Petritsch C; Beug H; Balmain A; Oft M Genes Dev; 2000 Dec; 14(24):3093-101. PubMed ID: 11124802 [TBL] [Abstract][Full Text] [Related]
19. A distinct nuclear localization signal in the N terminus of Smad 3 determines its ligand-induced nuclear translocation. Xiao Z; Liu X; Henis YI; Lodish HF Proc Natl Acad Sci U S A; 2000 Jul; 97(14):7853-8. PubMed ID: 10884415 [TBL] [Abstract][Full Text] [Related]
20. Identification of important regions in the cytoplasmic juxtamembrane domain of type I receptor that separate signaling pathways of transforming growth factor-beta. Saitoh M; Nishitoh H; Amagasa T; Miyazono K; Takagi M; Ichijo H J Biol Chem; 1996 Feb; 271(5):2769-75. PubMed ID: 8576253 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]